SWM
JAZZ icon

Spire Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Spire Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-201
Closed -$38K – 2309
2026
Q1 		$38K Buy
201
+133
+196% +$23.2K ﹤0.01% 1250
2025
Q4 		$11.6K Hold
68
– – ﹤0.01% 1662
2025
Q3 		$8.96K Buy
68
+19
+39% +$2.28K ﹤0.01% 1787
2025
Q2 		$5.2K Sell
49
-229
-82% -$24.9K ﹤0.01% 1929
2025
Q1 		$34.5K Buy
278
+161
+138% +$21K ﹤0.01% 1417
2024
Q4 		$14.4K Sell
117
-199
-63% -$23.5K ﹤0.01% 1732
2024
Q3 		$35.2K Buy
316
+200
+172% +$21.9K ﹤0.01% 1247
2024
Q2 		$12.4K Sell
116
-84
-42% -$9.23K ﹤0.01% 1581
2024
Q1 		$24.1K Buy
200
+144
+257% +$17.6K ﹤0.01% 1449
2023
Q4 		$6.53K Sell
56
-367
-87% -$45.8K ﹤0.01% 1884
2023
Q3 		$54.8K Buy
423
+238
+129% +$31.7K ﹤0.01% 1151
2023
Q2 		$22.9K Sell
185
-16
-8% -$2.15K ﹤0.01% 1539
2023
Q1 		$29.4K Buy
201
+182
+958% +$26.9K ﹤0.01% 1435
2022
Q4 		$3K Buy
19
+3
+19% +$440 ﹤0.01% 1966
2022
Q3 		$2K Sell
16
-185
-92% -$28.1K ﹤0.01% 1959
2022
Q2 		$31K Sell
201
-185
-48% -$28.5K ﹤0.01% 1490
2022
Q1 		$60K Sell
386
-105
-21% -$15.2K ﹤0.01% 1381
2021
Q4 		$63K Buy
491
+57
+13% +$7.49K ﹤0.01% 1609
2021
Q3 		$57K Buy
434
+36
+9% +$5.44K ﹤0.01% 1418
2021
Q2 		$71K Sell
398
-71
-15% -$12.3K ﹤0.01% 1335
2021
Q1 		$77K Buy
+469
New +$77.2K ﹤0.01% 1513

Other funds holding JAZZ

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

Spire Wealth Management's JAZZ Position: Q2 2026 in Review

Spire Wealth Management sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2026, closing a stake of 201 shares — an estimated $38K sold.

Spire Wealth Management first reported a position in JAZZ in Q1 2021 and held it in 21 quarters. The position peaked at $77K in Q1 2021. 87 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Spire Wealth Management reported no remaining Jazz Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Spire Wealth Management sold 201 Jazz Pharmaceuticals shares in Q2 2026, an estimated $38K.
  • Spire Wealth Management first reported a position in Jazz Pharmaceuticals in Q1 2021 and held it in 21 quarters.
  • Spire Wealth Management's Jazz Pharmaceuticals position peaked at $77K in Q1 2021.
  • 87 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.